Abstract: A device for use with an OR table for supporting a patient's head in a sniff position has a support assembly including a base and patient head support for mounting to an end of an OR table; a pneumatic or mechanical jack, or an expandable bellows, supporting the patient head support for raising or lowering the patient's head relative to the base; a rotatable axis allowing for flexion and extension of the neck; and a mounting assembly for mounting the support assembly to the end of the operating table.

Abstract: Embodiments of the present disclosure may comprise pieces necessary to assemble a container for a deceased individual. The pieces may fit together in such a way as to minimize storage footprint and transportation costs. The pieces may be comprised of different types of materials including, but not limited to and different wood grain colors, and different interior dressings. Embodiments of the present disclosure may incorporate designs for reasons such as style preference or religious symbols. Further, the design of the present disclosure may vary in shape and dimensions to accommodate differently-sized individuals. Embodiments of the present disclosure may be assembled quickly and without special tools.

Abstract: A sleeve for wear on a body limb includes a sleeve body and a strap body. The strap body includes straps with fasteners at or near the ends of the straps for attachment to the sleeve body. An arm sleeve includes a thumb opening connected to a tension strap that extends along the length of the sleeve. The arm sleeve is configured to apply a twisting force when the opening is placed on the thumb. An arm and shoulder sleeve includes a lower sleeve, and upper arm cover and straps extending from an elbow band to extend from the upper arm cover for attachment to another garment.

Abstract: A system for patient rehabilitation is disclosed. The system includes a first movable frame including an articulating bed, wherein the bed is configured to be selectively articulated to an inclined position, a suspension system, wherein the suspension system is disposed within the articulating bed and is selectively adjustable to accommodate varying patient height, a harness, wherein the harness is selectively engageable with the suspension system, wherein the harness is selectively adjustable to accommodate varying patient sizes, a second movable frame including a walker, wherein the walker includes a pair of legs and a motor, wherein approximation of the two movable frames permits the patient to easily utilize the walker from the bed. A method of using the system for patient rehabilitation is also disclosed.

Abstract: Aspects of the present disclosure relate aids for the visually impaired. An apparatus to assist a visually impaired person in navigating an environment includes a head-worn computer, a radar system mounted on the head-worn computer and positioned to measure distances to objects in the environment within an angular field in front of the visually impaired person wearing the head-worn computer, and a processor adapted to process the measured distances from the radar system and to identify objects in the environment that are within the angular field in front of the visually impaired person. The processor is further adapted to generate feedback cues to the visually impaired person in correspondence to the measured distances within the angular field in front of the visually impaired person as the visually impaired person moves his head from side to side while navigating the environment.

Abstract: A garment/device/support system, system and method for a wheelchair bound person includes one or two sleeves that are worn on the arms. The sleeves are connected by straps to a chassis or vest worn on the torso. The straps are affixed using Velcro or other fasteners that transfer motion of the wearer's arms to the chassis or vest. Motion, energy and stimulation are transferred to muscle groups, viscera, organs, and body parts in other parts of the body through the motion of the arms as the user moves about in the wheelchair. A cape may be affixed to the vest including shoulder straps connected to a center back portion and extending to a lower portion for positioning beneath and/or attaching to the user's hips or legs. A seat cushion and belt may be provided.

Abstract: A compression-resistant device includes least one pair of first and second opposing jaw members having respective engaging surfaces for movement from an open position receiving an object and a closed position engaging the object. A manual compression surface enables a user to manually apply pressure to urge the engaging surfaces from one of the closed position towards an open position or from the open position towards the closed position. At least one resistance member interfaces with the first and second opposing jaw members to resist pressure manually applied by a user urging the engaging surfaces from the closed position towards the open position or from the open position towards the closed position. The manual compression surface includes projections such that manually applied pressure forms at least one aggravated area on a finger surface of the user to initiate a callus. A corresponding method of operating the device is also disclosed.

Abstract: The present disclosure provides a compression stocking that comprises a tubular fabric body and a piezoelectric material that is incorporated into the tubular fabric body. The piezoelectric material changes shape in response to actuation energy to generate a compressive force. When the compression stocking is placed on a user's leg, the compressive force may compress blood vessels in the user's leg to assist with the return of venous blood.

Abstract: A massage device includes a base, a drive unit, and a transmission unit. The drive unit is coupled to the base. The transmission unit is disposed at one side of the base. The drive unit includes a drive member to drive a rotary shaft for driving massage members. One end of the rotary shaft is provided with a unidirectional bearing and a first bevel gear. The unidirectional bearing is able to control the rotation of the first bevel gear. The transmission unit includes two positioning blocks and a worm shaft connected between the two positioning blocks. The worm shaft is provided with a second bevel gear and a movable member thereon. The first bevel gear meshes with the second bevel gear. When the first bevel gear is rotated, the second bevel gear is driven to link other parts so that the drive unit can slide on the base.

Abstract: A primary object of the present invention is to provide an air bag and a massage machine which can allow a person to select one of an appropriate pressure massage and an appropriate massage with an air bag. An arm air bag portion 600 includes base bodies 610, 620 each containing a frame and a resin molding product, one or more protruding portions 630 for pressure provided on the base bodies 610, 620 and one or more expansion and contraction bags 640, 650, 660, 670, 690 provided on the base bodies 610, 620 and provided around the one or more protruding portions 630 for pressure. An expansion height of each of the one or more expansion and contraction bags 640, 650, 660, 670, 690 is higher than a protruding height H of each of the one or more protruding portions.

Abstract: A mask member which fits over a portion of the face of a user. A retaining member holds the mask in place on the user's head. Eye portions allow the user to see while wearing the mask. A treatment mechanism is positioned on an interior surface of the mask for skin treatment including treatment around the eyes. A control mechanism controls the treatment mechanism.

Abstract: A therapeutic, fitness, and sports enhancement device which includes a cylindrically shaped body having a predetermined density and predetermined diameter, the body including a plurality of projections of a predetermined shape. One or more of the predetermined density and the predetermined diameter in combination with the predetermined shape of the projections optimize mobilization of soft tissue structures of the human body.

Abstract: Systems and methods for cardiopulmonary resuscitation feedback are disclosed. According to an aspect, a method includes determining a force. The method also includes, in response to determining the force, acquiring spatial orientation data, remove the effects of gravity, and wirelessly or wired method of communicating the spatial orientation data.

Abstract: A system applies cardiopulmonary resuscitation (CPR) to a recipient. An automated controller is provided together with a compression device which periodically applies a force to a recipient's thorax under control of the automated controller. A band is adapted to be placed around a portion of the torso of the recipient corresponding to the recipient's thorax. A driver mechanism shortens and lengthens the circumference of the band. By shortening the circumference of the band, radial forces are created acting on at least lateral and anterior portions of the thorax. A translating mechanism may be. provided for translating the radial forces to increase the concentration of anterior radial forces acting on the anterior portion of the thorax. The driver mechanism may comprise a tension device for applying a circumference tensile force to the band. The driver mechanism may comprise an electric motor, a pneumatic linear actuator, or a contracting mechanism defining certain portions of the circumference of the band.

Abstract: A device and associated method for the dispensation of mists for therapeutic use, comprising: a dispensing member (2) for dispensing an air flow (3) within which micronized particles of a liquid or solid therapeutic substance are dispersed; a chamber (11) having at least one inlet (12) for said air flow (3) generated by the dispensing member (2) and at least one outlet (13) for said air flow (3) present inside the chamber (11) itself; and a communication conduit (10) interposed between said dispensing member (2) and said chamber (11) in order to introduce the air flow (3) into the chamber (11) itself; said chamber (11) being switchable between an operative condition of maximum volume in which it internally defines a space (20) for containing at least one user, and a non-operative condition of minimum volume suitable for transport and/or storage.

Abstract: An auricular peripheral nerve field stimulator system includes an electrical stimulation device for generating electrical stimulation signals and a plurality of therapy electrodes each electrically coupled to the electrical stimulation device and each including a plurality of needles for percutaneous insertion into an auricle of a human ear near at least one neural vascular bundle located therein. In some embodiments, at least one reference electrode electrically is coupled to the electrical stimulation device and includes at least one needle for percutaneous insertion into or adjacent the auricle to provide a ground reference for the electrical stimulation device. The generated electrical stimulation signals are, in any case, delivered by the percutaneously inserted needles to stimulate an auricular peripheral nerve field within the auricle.

Abstract: Various embodiments are described for a container for storage of a medicament, the container comprising a surface having at least a cavity configured to store at least one dose of the medicament; and a covering disposed over at least the cavity of the surface and comprising at least two adjacent edges and a set of perforations disposed on the covering and spaced apart from the at least two adjacent edges of the covering. A container comprising a sheet of separable units and methods for use are described.

Abstract: An object of the present invention is to automatically identify a direction, a posture and characteristics such as a shape, a size, a type and an expiration date of a medicine and store the medicine with ensuring a high degree of freedom. A medicine supplying apparatus 1 includes an identifying part and a storing part. A storing area is defined at the time of storing the medicine according to a size of a medicine contained in characteristics of the medicine identified by the identifying part. The medicine is stored in the storing part in a state that identification information of the medicine is associated with the storing area. Further, the medicine supplying apparatus has a determination processing part which can determine whether or not the medicine is a target to be treated based on the characteristics of the medicine identified by the identifying part.

Abstract: Several travel bags, carriers and coolers are available in the market. However, these carriers are suitable for transporting drugs under one condition and don't serve many of the patients (and in particular the elderly) who have prescribed drugs that need to be stored at different temperatures in one unit. These carriers are, also, costly and aren't tailored to solve the problems that encounter many researchers in the labs and many patients. Accordingly, they were not effective in solving the problems of the waste of the drugs due to their improper storage or in preventing the adverse effects that can result from the damage of the drugs. In contrast, the Medical Transport Bag is an economic transport system that can be used for transporting many samples and medicines in a cost-effective manner and under different controlled conditions in the same unit.

Abstract: Disclosed is a transfer device for use in reconstituting dry drugs and for diluting liquid drugs in drug containers. The transfer device includes a multi-port manifold and a connector suitable to be attached to a drug container, a first conduit to transfer a liquid entering an inlet port of the manifold through the connector and into the drug container, and a second conduit to transfer a gaseous fluid through the connector to an outlet port of the manifold. Also disclosed is a closed liquid transfer system which includes the transfer device, a tube connectable to the inlet port for transporting a liquid to the transfer device, a tube connectable to the outlet port for transporting the gaseous fluid away from the transfer device, and a gas collection container to collect the gaseous fluid in the gas transporting tube.

Abstract: Chronotherapeutic dosing can include receiving, using a processor, sensor data from a sensor for a user, wherein the sensor data is collected subsequent to the user starting a regimen for a medication, determining, using the processor, a biological marker from the sensor data, wherein the biological marker is correlated with the medication, and comparing, using the processor, the biological marker with an expected state of the biological marker based upon a dose time of the medication. Chronotherapeutic dosing can also include providing, using the processor, a notification indicating a result of the comparing.

Abstract: A plunger for movably mounting within a cavity or barrel of a syringe. The plunger includes a contact face having a flange movably mounted thereto, wherein the flange is movable between an open configuration wherein an opening is formed between the flange and a portion of the plunger, the opening configured for engagement with an IV hook or other engagement member, and a closed configuration wherein the upper surfaces of the contact face and the flange are generally planar with one another.

Abstract: Nutritional formulas comprising long-chain polyunsaturated fatty acids (LC-PUFAs) are provided, along with methods and devices for preparing and/or administering nutritional formulas. In some embodiments, a percentage of the LC-PUFAs in the nutritional formula are in the form of monoglycerides and/or free fatty acids. In some embodiments, the nutritional formulas do not comprise added lipase. Also provided are methods for providing nutrition to a subject, methods for improving fat absorption, methods for improving cognitive ability, methods for preventing chronic lung disease, and methods for reducing the length of time a patient requires total parenteral nutrition.

Abstract: Nutritional formulas comprising long-chain polyunsaturated fatty acids (LC-PUFAs) are provided, along with methods and devices for preparing and/or administering nutritional formulas. In some embodiments, a percentage of the LC-PUFAs in the nutritional formula are in the form of monoglycerides and/or free fatty acids. In some embodiments, the nutritional formulas do not comprise added lipase. Also provided are methods for providing nutrition to a subject, methods for improving fat absorption, methods for improving cognitive ability, methods for preventing chronic lung disease, and methods for reducing the length of time a patient requires total parenteral nutrition.

Abstract: The subject matter of the present invention is a cosmetic or pharmaceutical composition for controlled moisturizing and release of active molecule(s), comprising at least one emulsifier having an enzyme cleavable bound, at least one emollient, at least one polar solvent, and water, forming together a macroscopically homogenous liquid crystals emulsion. In some embodiments of the invention, the composition also includes at least one ingredient having a cosmetic or pharmaceutical activity.

Abstract: Aluminum chlorohydrate salts having an amount of Peak 1 material relative based on a total of Peaks 3, 4, and 5 of at least 20% as measured by size exclusion chromatography, together with water treatment compositions, antiperspirant compositions, and oral care compositions, comprising the same, and methods for making and using the same.

Abstract: The present invention provides an oral care composition comprising: (a) at least one zinc ion source; and (b) at least two active ingredients, wherein said active ingredients are selected from one or more of the following groups: (i) monoterpenoid phenols; (ii) monoterpenoid aldehydes; (iii) sesquiterpenoid alcohols; (iv) active compounds from an extract of oregano; and (v) active compounds from an extract of rosemary.

Abstract: The invention relates to a method of treating acne by the topical administration of an acne active ingredient in the presence of a) an anhydrous composition comprising a component that in the presence of water generates heat, and b) water. The invention also relates to an acne treatment kit comprising a first composition which is anhydrous and comprises a component that in the presence of water generates heat on the skin to which it is applied and a second composition which comprises an aqueous carrier, at least one of said compositions comprising an acne active ingredient, said compositions being stored in isolation from each other and being capable of generating heat when they are combined.

Abstract: The disclosure relates to compositions for treating keratinous substrates, such as the hair, comprising monoethanolamine and at least one carboxylic acid, as well as systems and methods for treating keratinous substrates with the compositions.

Abstract: Topical sanitizers including alcohol-based gels, alcohol-based foams, alcohol-free foams, liquid soaps, alcohol-based wipes, and alcohol-based sprays include avenanthramides, which is an active component of oats that is beneficial to the skin. The concentration of avenanthramides can be substantially less when considering the use profile of the person using the sanitizers. Many healthcare workers sanitize their hands dozens of times a day. An effective dose of avenanthramides can be delivered to the skin even when the concentration in avenanthramides is relatively low due to the repeated application of the sanitizers during the day. In addition, a lower concentration of avenanthramides may be used to maintain healthy skin compared to a higher concentration that may be used to repair damaged skin. Minimum concentrations of avenanthramides in one or more topical sanitizers can be determined according to the use profile and the target amount of avenanthramides to deliver via the topical sanitizers.

Abstract: The present invention provides a cleansing composition for skin or hair which can provide a good durability of foam and rinse feel, give good combability and softness from during rinsing to after drying while imparting manageability to hair when the cleansing composition is applied to hair, and give good moist feeling to skin when the cleansing composition is applied to skin. The cleansing composition for skin or hair is a cleansing composition comprising an internal olefin sulfonate (A) having 12 or more and 24 or less carbon atoms.

Abstract: A transparent cosmetic or personal care composition comprising: a) a polymeric thickener, b) a protein, c) an active material, which is selected from disaccharides, lactones, inorganic salts, diacids and mixtures thereof, d) a solubiliser, e) a pH adjuster, f) a dye g) water wherein the solubiliser comprises a mixture of at least two components, said mixture comprising at least one high HLB component having an HLB value of from 10 to 20 and at least one low HLB component having an HLB value of from 1 to less than 10, and wherein the dye comprises violet, blue, red or mixtures thereof.

Abstract: The present invention provides new peptides useful as skin whitening agents and their uses in cosmetic or therapeutic applications.

Abstract: The present invention relates to a cosmetic composition for coating keratin fibres, comprising: —an aqueous phase, —a surfactant system present at a total content of greater than or equal to 15% by weight relative to the total weight of the composition, said surfactant system comprising: i) at least one non-ionic surfactant with an HLB value at 25° C. of less than 8, and ii) at least one anionic surfactant with an HLB value at 25° C. of greater than or equal to 8, chosen from acyl glutamic acids and salts thereof, together forming a lamellar phase L?, and—at least one aqueous dispersion of particles of at least one film-forming polymer. The present invention also relates to a process for coating keratin fibres.

Abstract: Transparent cosmetic compositions include, based on the total weight thereof, a) 0.1 to 10 wt. % of a conditioning polymer; b) 0.5 to 25 wt. % of a thickening polymer; c) 0.01 to 30 wt. % of a film-forming polymer; d) 1 to 35 wt. % of a humectant; e) 0.1 to 6 wt. % of an acid, and f) 1 to 90 wt. % water. The cosmetic compositions are particularly suitable for temporarily reshaping keratin fibers, and in particular curly human hair.

Abstract: Disclosed is a hair conditioning composition comprising: a cationic surfactant; a high melting point fatty compound; a preformed emulsion and/or an ionic benefit agent, wherein the ionic benefit agents are those excluding ionic dyes, precursors thereof, and anionic surfactants; an alkyl ether and/or alkyl ester, preferably alkyl ether, of at least one of the following: polyethylene glycol, polypropylene glycol, polyglycerin, and mixtures thereof, and wherein the alkyl ether and/or alkyl ester has from about 50 to about 300 units of ethylene glycol, propylene glycol, glycerin and mixtures thereof; and an aqueous carrier. The composition of the present invention provides benefits from ionic benefit agents and/or preformed emulsions, while maintaining stability and wet conditioning of the composition.

Abstract: The present disclosure pertains to compositions that include branched amine functionalized silicone compounds, methods involving the application of such compounds to hair, methods for making hair conditioners using such compounds, and uses of compositions containing such compounds for conditioning of hair for one or both of reducing tangling and increasing the ease of combing.

Abstract: The invention relates to an oil-based cleansing product which contains abrasive particles as exfoliating substances. In one particular embodiment, salt and sugar crystals are used as exfoliating substances.

Abstract: An anhydrous personal care composition, comprising: (a) 45 to 60 weight % of at least one ester, selected from (i) triglycerides, (ii) diglycerides, (iii) monoglycerides, (iv) monoesters of diols, and (v) diesters of diols; (b) a first wax having a melting point of from 35° C. to 72° C. present in an amount of 5 to 25 weight %; (c) a second wax having a melting point of 73 to 90C present in an amount of 1 to 10 weight %; and (d) at least one plant oil having a saponification value of from 150 to 275 mg KOH/g present in an amount of 5 to 35 weight.

Abstract: The present disclosure provides a method for preparing an anti-wrinkle functional cosmetic substance comprising cutting herbal materials comprising angelica gigas root, rehmannia glutinosa root, a paeonia albiflora root, mentha arvensis, angelica dahurica root, scrophularia buergeriana, rheum undulatum root/stalk/stem, sanguisorba officinalis root, and cinnamomum cassia bark into pieces, putting a mixture of the herbal material pieces, talc, a pearl powder, deep ocean water into an extractor, sterilizing the mixture, then fermenting the mixture by mixed lactobacillales strain, and then hot-water extracting the mixture into a solid, freeze-drying the extracted solid into a freeze-dried powder, and dissolving and high-speed mixing the freeze-dried powder, adenosine, and borax in a beeswax, a perilla oil, an olea europaea (olive) fruit oil, and a helianthus annuus (sunflower) seed oil heated and chamaecyparis obtusa water heated.

Abstract: Biologically active extracts of one or more of Vigna sp., Terminalia sp. or Cocos nucifera and compositions containing one or more of the extracts for the maintenance and improvement of the health and/or appearance of the skin and/or an epidermal appendage.

Abstract: A method comprising topically applying to facial skin a composition comprising an aqueous, alcoholic, or aqueous-alcoholic extract from Nymphoides peltatum.

Abstract: Dissolvable unit dose constructs and their method of manufacture are disclosed in which the unit dose construct is formed by providing a first composition including a water soluble polymer and a liquid carrier, depositing the first composition onto a substrate, providing a second composition including a water soluble polymer and a liquid carrier, applying the second composition at a discrete location overlying the first composition by microdeposition; and removing at least a portion of the liquid carrier from the first composition to form the unit dose construct.

Abstract: The present invention provides a clear depot comprising at least one hydrophilic water-soluble pharmaceutically active agent selected from the group consisting of vancomycin, gentamicin, a pharmaceutically acceptable salt thereof and a mixture thereof, water, a phospholipid, an oil, optionally a pH adjusting agent, and a viscosity modifying agent selected from the group consisting of ethanol, isopropanol, and a mixture thereof, wherein the water present in the depot is no more than about 4 wt % relative to the total weight of the depot and the depot has a pH of between about 3 and about 6, method of making and administering same.

Abstract: Compositions and methods for the treatment of drug-induced long QT syndrome and other cardiac channelopathies are disclosed herein. The compositions and methods of the present invention comprise binding one or more QT prolonging drugs with a liposome prior to parenteral (intravenous or subcutaneous) administration, or administration of an empty liposome prior to or concomitantly with therapeutic agents known to have a high risk of QT prolongation, or immediately following an envenomation. The results presented show an abrogation of the adverse effects of QT prolonging drugs in a dose-dependent manner by the compositions of the present invention.

Abstract: Compositions containing an amorphous biologically active ingredient and porous particles materials are disclosed. Methods of making and using the compositions to provide topical and/or dermal compositions for the treatment of humans and animals are also disclosed.

Abstract: The present invention provides methods for preventing, inhibiting or treating a surgical site infection associated with a surgical operation comprising the step of applying to the surgical site a biocompatible, biodegradable substrate being impregnated and/or having its surface coated fully or partially with a matrix composition which provides local controlled and prolonged release of at least one pharmaceutically active agent at the surgical site.

Abstract: A process for forming microspheres is disclosed. The process includes contacting a solvent with a modified cellulose to form a solution; contacting the modified cellulose solution with at least one bioactive agent to form a discontinuous phase liquid; contacting the discontinuous phase liquid with a continuous phase liquid to form an emulsion; and contacting the emulsion with a third phase liquid to extract the solvent from the emulsion, thereby forming a plurality of modified cellulose microspheres.

Abstract: The tablets, compositions and methods of the present invention, comprising a carbonate salt of an aliphatic amine polymer and s monovalent anion can prevent or ameliorate acidosis, in particular acidosis in patients with renal disease. The tablets and compositions of the present invention maintain a disintegration time of no greater than 30 minutes at 37° C. and at pH of at least 1 for a period of at least ten weeks at 60° C. Furthermore, the tablets are stable for extended periods of time without the need for specialized storage conditions.

Abstract: The present invention provides a pharmaceutical product which includes a solid preparation comprising pitavastatin or a salt thereof, in which production of a lactone form thereof is suppressed. The pharmaceutical product is characterized by including a solid preparation comprising the following ingredients (A) and (B): (A) pitavastatin or a salt thereof; and (B) at least one member selected from the group consisting of carmellose and a salt thereof, crospovidone, and microcrystalline cellulose, and the solid preparation having a water content of 2.9 mass % or less, wherein the solid preparation is stored in a tight package.